---
title: "This powerful drug combo cuts prostate cancer deaths by 40%"
date: 2025-10-19T16:59:16.000Z
category: Health
externalLink: "https://www.sciencedaily.com/releases/2025/10/251019120507.htm"
image: ""
excerpt: "A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 patients worldwide and was led by Cedars-Sinai researchers. Experts call it a game changer that’s likely to reshape treatment guidelines for aggressive prostate cancer.…"
---